Submitted by Anonymous (not verified) on 11 March 2026 - 14:00
Opinion/decision on a Paediatric investigation plan (PIP): Spravato, esketamine hydrochloride, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Psychiatry, PIP number: EMA/PE/0000224110
Source: